Rankings
▼
Calendar
CMPX FY 2021 Earnings — Compass Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
CMPX
Compass Therapeutics, Inc.
$781M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$82M
Net Income
-$82M
EPS (Diluted)
$-1.31
Cash Flow
Operating Cash Flow
-$20M
Free Cash Flow
-$21M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$154M
Total Liabilities
$14M
Stockholders' Equity
$140M
Cash & Equivalents
$145M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$82M
-$28M
-194.4%
Net Income
-$82M
-$30M
-178.6%
← Q4 2020
All Quarters
Q1 2021 →